Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: A 5·25-year follow-up study

Clinical Endocrinology

Volumn 73, Issue 1, 2010, Pages 72-77

  Schalin Jäntti, Camilla ^a   Valanne, Leena ^a   Tenhunen, Mikko ^a   Setälä, Kirsi ^a   Paetau, Anders ^a   Sane, Timo ^a   Kouri, Mauri ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GROWTH HORMONE; KI 67 ANTIGEN;

ACROMEGALY; ADULT; AGED; ALLERGY; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DISEASE CONTROL; EYE IRRITATION; FATIGUE; FEMALE; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOTHERAPY; HAIR LOSS; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; HYPOPITUITARISM; MALE; MORTALITY; MYCOBACTERIOSIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTINOMA; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT; ADENOMA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PITUITARY NEOPLASMS; RADIATION DOSE FRACTIONATION;

ADENOMA; ADULT; AGED; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA; TREATMENT OUTCOME;

EID: 77953735367     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03755.x     Document Type: Article

References (31)

1. Chanson, P. (2005) Non-functioning pituitary adenomas. Journal of Endocrinological Investigation, 28, 93 99.
2. Jenkins, D., OBrien, I., Johnson, A. et al. (1995) The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clinical Endocrinology, 43, 517 522.
3. Sheaves, R., Jenkins, P., Blackburn, P. et al. (1996) Outcome of transphenoidal surgery for acromegaly using strict criteria for surgical cure. Clinical Endocrinology, 45, 407 413.
4. Colao, A., Di Sarno, A., Landi, M.L. et al. (1997) Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. Journal of Clinical Endocrinology and Metabolism, 82, 3574 3579.
5. Yu, C., Wu, Z. Gong, J. (2005) Combined treatment of invasive giant prolactinomas. Pituitary, 8, 61 65.
6. Wass, J.A.H. (1996) Long term effects of radiotherapy for acromegaly. Metabolism, 45, 107 108.
7. Tsagarakis, S., Grossman, A.B. Plowman, P.N. (1991) Megavoltage radiotherapy in the management of prolactinomas: long term follow-up. Clinical Endocrinology, 34, 399 406.
8. Brada, M., Ajithkumar, T.V. Minniti, G. (2004) Radiosurgery for pituitary adenomas. Clinical Endocrinology, 61, 531 543.
9. al-Mefty, O., Kersh, J.E., Routh, A. et al. (1991) The long-term side effects of radiation therapy for benign brain tumors in adults. Journal of Neurosurgery, 74, 502 512.
10. Millar, J.L., Spry, N.A., Lamb, D.S. et al. (1991) Blindness in patients after external beam radiation for pituitary adenomas: two cases occurring after small daily fractional doses. Clinical Oncology, 3, 291 294.
11. McCord, M.W., Buatti, J.M., Fennell, E.M. et al. (1997) Radiotherapy for pituitary adenoma: long term outcome and sequelae. International Journal of Radiation Oncology Biology Physics, 39, 437 444.
12. Erfurth, E.M. Hagmar, L. (2005) Cerebrovascular disease in patients with pituitary tumors. Trends in Endocrinology and Metabolism, 16, 334 342.
13. Ayuk, J., Clayton, N., Holder, G. et al. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 84, 1613 1617.
14. Kauppinen-Mäkelin, R., Sane, T., Reunanen, A. et al. (2005) A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 4081 4086.
15. Therasse, P., Arbuck, S.G., Eisenhauer, E.A. et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute, 92, 205 216. (Pubitemid 30099779)
16. Losa, M., Valle, M., Mortini, P. et al. (2004) Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. Journal of Neurosurgery, 100, 438 444.
17. Colin, P., Jovenin, N., Delemer, B. et al. (2005) Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. International Journal of Radiation Oncology Biology Physics, 62, 333 341.
18. Thapar, K., Kovacs, K., Scheithauer, B.W. et al. (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery, 38, 99 106.
19. Attanasio, R., Epaminonda, P., Motti, E. et al. (2003) Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. Journal of Clinical Endocrinology and Metabolism, 88, 3105 3112.
20. Tung, G.A., Noren, G., Rogg, J.M. et al. (2001) MR imaging of pituitary adenomas after gamma knife stereotactic radiosurgery. American Journal of Roentgenology, 177, 919 924.
21. Minniti, G., Traish, D., Ashley, S. et al. (2006) Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clinical Endocrinology, 64, 542 548.
22. Sheehan, J.P., Kondziolka, D., Flickinger, J. et al. (2002) Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. Journal of Neurosurgery, 97 (Suppl 5 408 414.
23. Lancranjan, I. Atkinson, A.B. (1999) Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group. Pituitary, 1, 105 114.
24. Turner, H.E., Vadivale, A., Keenan, J. et al. (1999) A comparison of lanreotide and ocreotide LAR for treatment of acromegaly. Clinical Endocrinology, 51, 275 280.
25. Jenkins, P.J. (2000) The use of long-acting somatostatin analogues in acromegaly. Growth Hormone and IGF Research, 10 (Suppl B S111 S114.
26. Milker-Zabel, S., Zabel, A., Huber, P. et al. (2004) Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. International Journal of Radiation Oncology Biology Physics, 59, 1088 1096.
27. Castinetti, F., Taieb, D., Kuhn, J.-M. et al. (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. Journal of Clinical Endocrinology and Metabolism, 90, 4483 4488.
28. Corsello, S.M., Ubertini, G., Altomare, M. et al. (2003) Giant prolactinomas in men: efficacy of cabergoline treatment. Clinical Endocrinology, 58, 662 670.
29. Gillam, M.P., Molitch, M.E., Lombardi, G. et al. (2006) Advances in the treatment of prolactinomas. Endocrine Reviews, 27, 485 534.
30. Grebe, S.K., Delahunt, J.W. Feek, C.M. (1992) Treatment of extensively invasive (giant) prolactinomas with bromocriptine. New Zealand Medical Journal, 105, 129 131.
31. Pouratian, N., Sheehan, J., Jagannathan, J. et al. (2006) Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery, 59, 255 256.